Search Results
Department of Pathology & Molecular Medicine, Queen’s University, Kingston, Ontario, Canada
Search for other papers by Eric Y Lian in
Google Scholar
PubMed
Department of Pathology & Molecular Medicine, Queen’s University, Kingston, Ontario, Canada
Search for other papers by Sarah M Maritan in
Google Scholar
PubMed
Department of Pathology & Molecular Medicine, Queen’s University, Kingston, Ontario, Canada
Search for other papers by Jessica G Cockburn in
Google Scholar
PubMed
Search for other papers by Katayoon Kasaian in
Google Scholar
PubMed
Department of Pathology & Molecular Medicine, Queen’s University, Kingston, Ontario, Canada
Search for other papers by Mathieu J F Crupi in
Google Scholar
PubMed
Search for other papers by David Hurlbut in
Google Scholar
PubMed
Department of Medical Genetics, University of British Columbia, British Columbia Cancer Research Centre, Vancouver, British Columbia, Canada
Search for other papers by Steven J M Jones in
Google Scholar
PubMed
Search for other papers by Sam M Wiseman in
Google Scholar
PubMed
Department of Pathology & Molecular Medicine, Queen’s University, Kingston, Ontario, Canada
Search for other papers by Lois M Mulligan in
Google Scholar
PubMed
share the first 1063 residues but have 9 or 51 unique C-terminal amino acids, respectively ( Mulligan 2014 ). RET isoforms are generally co-expressed but have distinct molecular and functional properties. RET9 and RET51 differ in membrane localisation
Search for other papers by Tirtha K Das in
Google Scholar
PubMed
Search for other papers by Ross L Cagan in
Google Scholar
PubMed
: genetic screens To model RET M918T (the RET isoform associated with MEN2B) Drosophila RET M955T was targeted to the developing eye, a well characterized epithelia in terms of cell–cell interactions and signal transduction ( Read et al . 2005 ). RET
Search for other papers by Maria Grazia Borrello in
Google Scholar
PubMed
Search for other papers by Antonella Aiello in
Google Scholar
PubMed
Search for other papers by Bernard Peissel in
Google Scholar
PubMed
Search for other papers by Maria Grazia Rizzetti in
Google Scholar
PubMed
Search for other papers by Piera Mondellini in
Google Scholar
PubMed
Search for other papers by Debora Degl'Innocenti in
Google Scholar
PubMed
Search for other papers by Veronica Catalano in
Google Scholar
PubMed
Search for other papers by Morena Gobbo in
Google Scholar
PubMed
Search for other papers by Paola Collini in
Google Scholar
PubMed
Search for other papers by Italia Bongarzone in
Google Scholar
PubMed
Search for other papers by Marco A Pierotti in
Google Scholar
PubMed
Search for other papers by Angela Greco in
Google Scholar
PubMed
Search for other papers by Ettore Seregni in
Google Scholar
PubMed
performed on pCDNA3 eukaryotic expression vector carrying the two RET isoforms ( RET9 or RET51 ) to obtain the following mutants: RET9 -K666E, RET51 -K666E, RET9 -G691S, RET51 -G691S, RET9 -K666E–G691S, and RET51 -K666E–G691S. To assess the quality
Laboratory of Endocrine and Metabolic Research, Istituto Auxologico Italiano IRCCS, Milan, Italy
Search for other papers by Giovanni Vitale in
Google Scholar
PubMed
Search for other papers by Germano Gaudenzi in
Google Scholar
PubMed
Search for other papers by Luisa Circelli in
Google Scholar
PubMed
Search for other papers by Marco F Manzoni in
Google Scholar
PubMed
Search for other papers by Andrea Bassi in
Google Scholar
PubMed
Search for other papers by Niccolò Fioritti in
Google Scholar
PubMed
Search for other papers by Antongiulio Faggiano in
Google Scholar
PubMed
Search for other papers by Annamaria Colao in
Google Scholar
PubMed
Search for other papers by on behalf of NIKE Group in
Google Scholar
PubMed
Ret gene ( Table 1 ). Table 1 Genetically engineered mouse models of medullary thyroid cancer carrying RET mutations. RET mutation RET isoform Promoter Background strain Tumor phenotype Reference C634R RET9 Rat
Search for other papers by Francesca Carlomagno in
Google Scholar
PubMed
Search for other papers by Teresa Guida in
Google Scholar
PubMed
Search for other papers by Suresh Anaganti in
Google Scholar
PubMed
Search for other papers by Livia Provitera in
Google Scholar
PubMed
Search for other papers by Svend Kjaer in
Google Scholar
PubMed
Search for other papers by Neil Q McDonald in
Google Scholar
PubMed
Search for other papers by Anderson J Ryan in
Google Scholar
PubMed
Search for other papers by Massimo Santoro in
Google Scholar
PubMed
type . Japanese Journal of Cancer Research 90 1231 – 1237 . Vidal M Wells S Ryan A Cagan R 2005 ZD6474 suppresses oncogenic RET isoforms in a Drosophila model for type 2 multiple endocrine neoplasia syndromes and papillary thyroid
Search for other papers by Donata Vitagliano in
Google Scholar
PubMed
Search for other papers by Valentina De Falco in
Google Scholar
PubMed
Search for other papers by Anna Tamburrino in
Google Scholar
PubMed
Search for other papers by Sabrina Coluzzi in
Google Scholar
PubMed
Search for other papers by Giancarlo Troncone in
Google Scholar
PubMed
Search for other papers by Gennaro Chiappetta in
Google Scholar
PubMed
Search for other papers by Fortunato Ciardiello in
Google Scholar
PubMed
Search for other papers by Giampaolo Tortora in
Google Scholar
PubMed
Search for other papers by James A Fagin in
Google Scholar
PubMed
Search for other papers by Anderson J Ryan in
Google Scholar
PubMed
Search for other papers by Francesca Carlomagno in
Google Scholar
PubMed
Search for other papers by Massimo Santoro in
Google Scholar
PubMed
clinical applications . Nature Clinical Practice. Oncology 5 521 – 530 doi:10.1038/ncponc1161 . Vidal M Wells S Ryan A Cagan R 2005 ZD6474 suppresses oncogenic RET isoforms in a Drosophila model for type 2 multiple endocrine neoplasia
Search for other papers by Maria Domenica Castellone in
Google Scholar
PubMed
Dipartimento di Medicina Molecolare e Biotecnologie Mediche, University of Naples ‘Federico II’, Naples, Italy
Search for other papers by Rosa Marina Melillo in
Google Scholar
PubMed
2002 ). Three RET isoforms (RET9, RET43 and RET51) encoding for protein variants differing in the intracellular tyrosines involved in RET activation ( Tahira et al . 1990 , Lorenzo et al . 1995 , Matera et al . 2000 ) have been described. RET is
Department of Pathology and Molecular Medicine, Queen’s University, Kingston, Ontario, Canada
Search for other papers by Lois M Mulligan in
Google Scholar
PubMed
Rekab AN Lian EY Wagner SM Antonescu CN Mulligan LM 2017 Differential recruitment of E3 ubiquitin ligase complexes regulates RET isoform internalization . Journal of Cell Science 130 3282 – 3296 . ( https://doi.org/10.1242/jcs.203885 ) 28794017
Institute of Molecular Pathology and Immunology of the University of Porto (IPATIMUP) – Cancer Biology, Molecular Pathology Service, Endocrinology Service of the Portuguese Institute of Oncology of Coimbra FG, Department of Pathology, Rua Dr Roberto Frias, s/n, 4200-465 Porto, Portugal
Institute of Molecular Pathology and Immunology of the University of Porto (IPATIMUP) – Cancer Biology, Molecular Pathology Service, Endocrinology Service of the Portuguese Institute of Oncology of Coimbra FG, Department of Pathology, Rua Dr Roberto Frias, s/n, 4200-465 Porto, Portugal
Search for other papers by Hugo Prazeres in
Google Scholar
PubMed
Search for other papers by Joana P Couto in
Google Scholar
PubMed
Search for other papers by Fernando Rodrigues in
Google Scholar
PubMed
Search for other papers by João Vinagre in
Google Scholar
PubMed
Search for other papers by Joana Torres in
Google Scholar
PubMed
Search for other papers by Vitor Trovisco in
Google Scholar
PubMed
Search for other papers by Teresa C Martins in
Google Scholar
PubMed
Institute of Molecular Pathology and Immunology of the University of Porto (IPATIMUP) – Cancer Biology, Molecular Pathology Service, Endocrinology Service of the Portuguese Institute of Oncology of Coimbra FG, Department of Pathology, Rua Dr Roberto Frias, s/n, 4200-465 Porto, Portugal
Search for other papers by Manuel Sobrinho-Simões in
Google Scholar
PubMed
Institute of Molecular Pathology and Immunology of the University of Porto (IPATIMUP) – Cancer Biology, Molecular Pathology Service, Endocrinology Service of the Portuguese Institute of Oncology of Coimbra FG, Department of Pathology, Rua Dr Roberto Frias, s/n, 4200-465 Porto, Portugal
Search for other papers by Paula Soares in
Google Scholar
PubMed
screening was performed in DNA obtained from peripheral blood leucocytes, by PCR amplification and direct Sanger sequencing of exons 8, 10, 11, and 13–16. Site-directed mutagenesis A pRcCMV vector expressing RET isoform 51 (i51) was mutated to generate the
Search for other papers by Lucieli Ceolin in
Google Scholar
PubMed
Search for other papers by Marta Amaro da Silveira Duval in
Google Scholar
PubMed
Search for other papers by Antônio Felippe Benini in
Google Scholar
PubMed
Search for other papers by Carla Vaz Ferreira in
Google Scholar
PubMed
Search for other papers by Ana Luiza Maia in
Google Scholar
PubMed
three RET isoforms, but the tyrosine residue 1096 is present only in the long (RET 51) isoform. RET is a receptor tyrosine kinase essential for the normal development and maturation of different tissues. Under normal conditions, RET is activated by a